Data Insights
Artificial Intelligence (10)
Big Data (3)
Biosimilars (5)
Blockchain (1)
Cell & Gene Therapy (13)
Chemotherapy (1)
Cloud (1)
Corporate Governance (3)
Covid-19 (5)
Cybersecurity (4)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (1)
Environmental Sustainability (6)
Future of Work (2)
Genomics (10)
Health & Wellness (1)
Immuno-oncology (19)
Immunotherapy (1)
Individualism & Expression (1)
Internet of Things (2)
Microbiome (1)
Mobile Health (1)
Nanomedicine (2)
Oncology (4)
Orphan Designated Drugs (4)
Other Innovation Areas (87)
Personalization (1)
Precision and Personalized Medicine (1)
Remote Patient Monitoring (1)
Renewable Energy (1)
Robotics (2)
Small molecules (1)
Smart Hospitals (2)
Social Responsibility (3)
Virtual Care (2)
Showing 2 results out of 2
![](https://pr-fr-solr-b2b-gdm-figaro1.pantheonsite.io/pharmaceutical-technology/wp-content/plugins/wpsolr-pro-gd/wpsolr/core/images/gif-load.gif)
How smart hospitals M&A performed in the pharmaceutical industry in Q1 2024
Analysis of the key themes driving M&A activity reveals that smart hospitals accounted for 16 pharmaceutical deals announced in Q1...
Q1 2024 update: smart hospitals related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that smart hospitals accounted for 2 pharmaceutical deals announced...